Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CYDY
Stock Latest News
The Fly
CytoDyn files $100M mixed securities shelf
1M ago
CYDY
Premium
The Fly
CytoDyn announces survival data in patients with mCRC treated with leronlimab
2M ago
CYDY
Premium
The Fly
CytoDyn announces first patient dosed in Phase II oncology trial
2M ago
CYDY
Premium
The Fly
CytoDyn announces data on mechanism of action of leronlimab
4M ago
CYDY
Premium
Company Announcements
CytoDyn Appoints Robert Hoffman as New CFO
4M ago
8K
CYDY
Premium
The Fly
CytoDyn appoints Robert Hoffman as CFO
4M ago
CYDY
Premium
The Fly
CytoDyn leadership team to attend ESMO Breast Cancer meeting
4M ago
CYDY
Premium
The Fly
CytoDyn CEO writes March 2025 letter to shareholders
6M ago
CYDY
Premium
The Fly
CytoDyn announces survival observations in mTNBC patients
6M ago
CYDY
Premium
The Fly
CytoDyn announces results from preclinical studies with SMC
7M ago
CYDY
Premium
The Fly
CytoDyn CEO believes current strategy will result in ‘significant value return’
9M ago
CYDY
Premium
The Fly
CytoDyn appoints Richard Pestell as lead consultant in oncology
9M ago
CYDY
Premium
The Fly
CytoDyn announces FDA clearance of Phase II oncology trial
10M ago
CYDY
Premium
The Fly
CytoDyn appoints Melissa Palmer as lead consultant in hepatology
10M ago
CYDY
Premium
The Fly
CytoDyn appoints Max Lataillade as head of clinical development
11M ago
CYDY
Premium
The Fly
CytoDyn engages Syneos Health as CRO for Phase II oncology trial
11M ago
CYDY
Premium
The Fly
CytoDyn announces preliminary findings in study with SMC Laboratories
11M ago
CYDY
Premium
The Fly
CytoDyn CEO says leronlimab has ‘potential to be life-changing therapeutic’
12M ago
CYDY
Premium
The Fly
CytoDyn engages CRO for Phase II inflammation trial
1y ago
CYDY
Premium
The Fly
CytoDyn completes FDA meeting on Phase II Study of leronlimab
1y ago
CYDY
Premium
Company Announcements
CytoDyn Resolves Lawsuit, Secures Payments, and Clears Debt
1y ago
8K
CYDY
Premium
The Fly
CytoDyn announces settlement with Amarex Clinical Research
1y ago
CYDY
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
